← Eichor
Study identifier: NCT04505618 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Condition: Diabetic Retinopathy · Retinal Vein Occlusion · Hypertension,Essential  ·  Sponsor: Johns Hopkins University

PhaseNA
Planned participants1050
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Amir H Kashani, MD, PhD  ·  410-502-2789  ·  akashan1@jhmi.edu

Ana C Martinez, MPH  ·  410-502-2789  ·  acollaz5@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Wilmer Eye InstituteBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04505618